$IDXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEXX LABORATORIES INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IDEXX LABORATORIES INC /DE. Get notifications about new insider transactions in IDEXX LABORATORIES INC /DE for free.
Page: < prev 1 2 3 4 5 6 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 505 | 0 | 11,399 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 459 | 0 | 11,904 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 737 | 0 | 12,363 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | A | 0.00 | 2,757 | 0 | 13,100 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | A | 598.49 | 183 | 109,523 | 183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | A | 598.49 | 9,717 | 5,815,508 | 9,717 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | A | 544.08 | 17,674 | 9,616,070 | 17,674 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Payment of Exercise | F | 544.08 | 1,447 | 787,284 | 43,090 | 44.5 K to 43.1 K (-3.25 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 974 | 0 | 44,537 | 43.6 K to 44.5 K (+2.24 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 435 | 0 | 43,563 | 43.1 K to 43.6 K (+1.01 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 505 | 0 | 43,128 | 42.6 K to 43.1 K (+1.18 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 459 | 0 | 42,623 | 42.2 K to 42.6 K (+1.09 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 737 | 0 | 42,164 | 41.4 K to 42.2 K (+1.78 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 174 | 0 | 2,308 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 181 | 0 | 2,482 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 196 | 0 | 2,663 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 212 | 0 | 2,859 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 221 | 0 | 3,071 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | A | 0.00 | 643 | 0 | 3,292 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | A | 544.08 | 6,003 | 3,266,112 | 6,003 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Sell | S | 545.00 | 850 | 463,250 | 3,624 | 4.5 K to 3.6 K (-19.00 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Payment of Exercise | F | 544.08 | 314 | 170,841 | 4,474 | 4.8 K to 4.5 K (-6.56 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 174 | 0 | 4,768 | 4.6 K to 4.8 K (+3.79 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 181 | 0 | 4,594 | 4.4 K to 4.6 K (+4.10 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 196 | 0 | 4,413 | 4.2 K to 4.4 K (+4.65 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 212 | 0 | 4,217 | 4 K to 4.2 K (+5.29 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 221 | 0 | 4,005 | 3.8 K to 4 K (+5.84 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 174 | 0 | 1,882 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 127 | 0 | 2,056 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 126 | 0 | 2,183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 88 | 0 | 2,309 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 199 | 0 | 2,397 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | A | 0.00 | 643 | 0 | 2,596 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | A | 544.08 | 6,003 | 3,266,112 | 6,003 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Payment of Exercise | F | 544.08 | 216 | 117,521 | 8,083 | 8.3 K to 8.1 K (-2.60 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 174 | 0 | 8,299 | 8.1 K to 8.3 K (+2.14 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 127 | 0 | 8,125 | 8 K to 8.1 K (+1.59 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 126 | 0 | 7,998 | 7.9 K to 8 K (+1.60 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 88 | 0 | 7,872 | 7.8 K to 7.9 K (+1.13 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 199 | 0 | 7,784 | 7.6 K to 7.8 K (+2.62 %) |
Feb 16 2021 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | M | 160.28 | 3,046 | 488,213 | 0 | |
Feb 16 2021 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Sell | S | 538.20 | 3,046 | 1,639,357 | 3,321 | 6.4 K to 3.3 K (-47.84 %) |
Feb 16 2021 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Buy | M | 160.28 | 3,046 | 488,213 | 6,367 | 3.3 K to 6.4 K (+91.72 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | M | 85.00 | 5,902 | 501,670 | 0 | |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | M | 64.69 | 5,974 | 386,458 | 0 | |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 10,217 | 0 | 10,217 | 0 to 10.2 K |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 10,217 | 0 | 0 | 10.2 K to 0 (-100.00 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 10,217 | 0 | 10,217 | 0 to 10.2 K |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 10,217 | 0 | 0 | 10.2 K to 0 (-100.00 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 492.40 | 300 | 147,718 | 0 | 300 to 0 (-100.00 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 491.56 | 1,100 | 540,716 | 300 | 1.4 K to 300 (-78.57 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 490.70 | 3,399 | 1,667,879 | 1,400 | 4.8 K to 1.4 K (-70.83 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 489.23 | 4,286 | 2,096,836 | 4,799 | 9.1 K to 4.8 K (-47.18 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 488.24 | 2,791 | 1,362,666 | 9,085 | 11.9 K to 9.1 K (-23.50 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 11,876 | 0 | 11,876 | 0 to 11.9 K |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 11,876 | 0 | 0 | 11.9 K to 0 (-100.00 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Buy | M | 85.00 | 5,902 | 501,670 | 11,876 | 6 K to 11.9 K (+98.79 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Buy | M | 64.69 | 5,974 | 386,458 | 5,974 | 0 to 6 K |
Feb 03 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 478.68 | 13 | 6,223 | 2,875 | 2.9 K to 2.9 K (+0.45 %) |
Feb 03 2021 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 478.68 | 42 | 20,105 | 993 | 951 to 993 (+4.42 %) |
Dec 03 2020 | IDXX | IDEXX LABORATORIES ... | COLLINS Asha | Director | Option Exercise | A | 467.86 | 358 | 167,494 | 358 | |
Dec 03 2020 | IDXX | IDEXX LABORATORIES ... | COLLINS Asha | Director | Option Exercise | A | 0.00 | 109 | 0 | 109 | |
Dec 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 67.85 | 12,801 | 868,548 | 3,227 | |
Dec 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 456.49 | 12,801 | 5,843,566 | 12,922 | 25.7 K to 12.9 K (-49.76 %) |
Dec 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 67.85 | 12,801 | 868,548 | 25,723 | 12.9 K to 25.7 K (+99.06 %) |
Dec 02 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Gift | G | 0.00 | 2,889 | 0 | 686,857 | 689.7 K to 686.9 K (-0.42 %) |
Nov 12 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Option Exercise | M | 85.00 | 5,902 | 501,670 | 0 | |
Nov 12 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Sell | S | 435.91 | 5,857 | 2,553,125 | 14,696 | 20.6 K to 14.7 K (-28.50 %) |
Nov 12 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Sell | S | 435.92 | 45 | 19,616 | 20,553 | 20.6 K to 20.6 K (-0.22 %) |
Nov 12 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Buy | M | 85.00 | 5,902 | 501,670 | 20,598 | 14.7 K to 20.6 K (+40.16 %) |
Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 478.13 | 3,000 | 1,434,380 | 18,050 | 21.1 K to 18.1 K (-14.25 %) |
Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 476.89 | 2,100 | 1,001,466 | 21,050 | 23.2 K to 21.1 K (-9.07 %) |
Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 475.50 | 300 | 142,650 | 23,150 | 23.5 K to 23.2 K (-1.28 %) |
Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 475.02 | 3,338 | 1,585,625 | 23,450 | 26.8 K to 23.5 K (-12.46 %) |
Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 474.14 | 1,241 | 588,404 | 26,788 | 28 K to 26.8 K (-4.43 %) |
Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 472.88 | 21 | 9,931 | 28,029 | 28.1 K to 28 K (-0.07 %) |
Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 471.34 | 1,700 | 801,283 | 709,991 | 711.7 K to 710 K (-0.24 %) |
Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 470.44 | 1,688 | 794,102 | 711,691 | 713.4 K to 711.7 K (-0.24 %) |
Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 469.76 | 1,899 | 892,082 | 713,379 | 715.3 K to 713.4 K (-0.27 %) |
Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 468.17 | 900 | 421,351 | 715,278 | 716.2 K to 715.3 K (-0.13 %) |
Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 466.86 | 283 | 132,120 | 716,178 | 716.5 K to 716.2 K (-0.04 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Sell | S | 470.08 | 2,098 | 986,228 | 7,571 | 9.7 K to 7.6 K (-21.70 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 79.54 | 36,216 | 2,880,621 | 0 | |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 481.26 | 200 | 96,252 | 24,700 | 24.9 K to 24.7 K (-0.80 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 480.31 | 566 | 271,854 | 24,900 | 25.5 K to 24.9 K (-2.22 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 479.69 | 1,534 | 735,851 | 25,466 | 27 K to 25.5 K (-5.68 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 477.02 | 390 | 186,036 | 27,000 | 27.4 K to 27 K (-1.42 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 476.01 | 3,596 | 1,711,740 | 27,390 | 31 K to 27.4 K (-11.61 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 475.20 | 3,474 | 1,650,846 | 30,986 | 34.5 K to 31 K (-10.08 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 473.97 | 244 | 115,648 | 34,460 | 34.7 K to 34.5 K (-0.70 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 473.04 | 2,407 | 1,138,602 | 34,704 | 37.1 K to 34.7 K (-6.49 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 472.20 | 1,107 | 522,721 | 37,111 | 38.2 K to 37.1 K (-2.90 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 471.02 | 2,493 | 1,174,259 | 38,218 | 40.7 K to 38.2 K (-6.12 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 469.80 | 2,850 | 1,338,921 | 40,711 | 43.6 K to 40.7 K (-6.54 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 469.09 | 9,617 | 4,511,281 | 43,561 | 53.2 K to 43.6 K (-18.08 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 467.97 | 6,338 | 2,965,970 | 53,178 | 59.5 K to 53.2 K (-10.65 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 467.01 | 1,400 | 653,820 | 59,516 | 60.9 K to 59.5 K (-2.30 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 79.54 | 36,216 | 2,880,621 | 60,916 | 24.7 K to 60.9 K (+146.62 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 476.73 | 400 | 190,692 | 716,461 | 716.9 K to 716.5 K (-0.06 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 471.17 | 200 | 94,234 | 716,861 | 717.1 K to 716.9 K (-0.03 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 470.99 | 25 | 11,775 | 717,061 | 717.1 K to 717.1 K (0.00 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 470.36 | 1,165 | 547,965 | 717,086 | 718.3 K to 717.1 K (-0.16 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 468.39 | 1,525 | 714,294 | 718,251 | 719.8 K to 718.3 K (-0.21 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 467.68 | 5,007 | 2,341,666 | 719,776 | 724.8 K to 719.8 K (-0.69 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 466.16 | 2,259 | 1,053,058 | 724,783 | 727 K to 724.8 K (-0.31 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 465.10 | 3,707 | 1,724,142 | 727,042 | 730.7 K to 727 K (-0.51 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 463.55 | 846 | 392,163 | 730,749 | 731.6 K to 730.7 K (-0.12 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 489.51 | 300 | 146,853 | 731,595 | 731.9 K to 731.6 K (-0.04 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 479.62 | 400 | 191,848 | 731,895 | 732.3 K to 731.9 K (-0.05 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 476.64 | 307 | 146,329 | 732,295 | 732.6 K to 732.3 K (-0.04 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 475.73 | 1,900 | 903,892 | 732,602 | 734.5 K to 732.6 K (-0.26 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 474.60 | 207 | 98,241 | 734,502 | 734.7 K to 734.5 K (-0.03 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 473.40 | 1,172 | 554,826 | 734,709 | 735.9 K to 734.7 K (-0.16 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 472.52 | 1,500 | 708,776 | 735,881 | 737.4 K to 735.9 K (-0.20 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 471.20 | 300 | 141,360 | 737,381 | 737.7 K to 737.4 K (-0.04 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 470.09 | 900 | 423,079 | 737,681 | 738.6 K to 737.7 K (-0.12 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 469.12 | 3,068 | 1,439,268 | 738,581 | 741.6 K to 738.6 K (-0.41 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 467.97 | 800 | 374,376 | 741,649 | 742.4 K to 741.6 K (-0.11 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 465.79 | 1 | 466 | 742,449 | 742.5 K to 742.4 K (0.00 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 461.80 | 85 | 39,253 | 742,450 | 742.5 K to 742.5 K (-0.01 %) |
Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 459.99 | 500 | 229,995 | 742,535 | 743 K to 742.5 K (-0.07 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 446.98 | 300 | 134,094 | 743,035 | 743.3 K to 743 K (-0.04 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 446.02 | 908 | 404,982 | 743,335 | 744.2 K to 743.3 K (-0.12 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 444.69 | 3,011 | 1,338,974 | 744,243 | 747.3 K to 744.2 K (-0.40 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 443.84 | 3,622 | 1,607,596 | 747,254 | 750.9 K to 747.3 K (-0.48 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 442.14 | 1,357 | 599,981 | 750,876 | 752.2 K to 750.9 K (-0.18 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 440.09 | 400 | 176,036 | 752,233 | 752.6 K to 752.2 K (-0.05 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 439.56 | 700 | 307,691 | 752,633 | 753.3 K to 752.6 K (-0.09 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 437.32 | 134 | 58,601 | 753,333 | 753.5 K to 753.3 K (-0.02 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 440.23 | 100 | 44,023 | 753,467 | 753.6 K to 753.5 K (-0.01 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 439.59 | 800 | 351,675 | 753,567 | 754.4 K to 753.6 K (-0.11 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 438.54 | 400 | 175,417 | 754,367 | 754.8 K to 754.4 K (-0.05 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 436.70 | 300 | 131,010 | 754,767 | 755.1 K to 754.8 K (-0.04 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 435.53 | 773 | 336,662 | 755,067 | 755.8 K to 755.1 K (-0.10 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 434.47 | 1,285 | 558,296 | 755,840 | 757.1 K to 755.8 K (-0.17 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 433.42 | 1,015 | 439,922 | 757,125 | 758.1 K to 757.1 K (-0.13 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 432.28 | 500 | 216,140 | 758,140 | 758.6 K to 758.1 K (-0.07 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 430.72 | 2,102 | 905,368 | 758,640 | 760.7 K to 758.6 K (-0.28 %) |
Nov 04 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 429.94 | 2,725 | 1,171,572 | 760,742 | 763.5 K to 760.7 K (-0.36 %) |
Nov 02 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 424.82 | 15 | 6,372 | 2,862 | 2.8 K to 2.9 K (+0.53 %) |
Nov 02 2020 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 424.82 | 47 | 19,967 | 951 | 904 to 951 (+5.20 %) |
Sep 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 67.85 | 6,000 | 407,100 | 16,028 | |
Sep 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 79.54 | 1,316 | 104,675 | 0 | |
Sep 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 389.08 | 1,285 | 499,965 | 12,906 | 14.2 K to 12.9 K (-9.06 %) |
Sep 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 388.79 | 2,788 | 1,083,952 | 14,191 | 17 K to 14.2 K (-16.42 %) |
Sep 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 387.33 | 3,243 | 1,256,103 | 16,979 | 20.2 K to 17 K (-16.04 %) |
Sep 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 67.85 | 6,000 | 407,100 | 20,222 | 14.2 K to 20.2 K (+42.19 %) |
Sep 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 79.54 | 1,316 | 104,675 | 14,222 | 12.9 K to 14.2 K (+10.20 %) |